Arkolith/Insider Trading/ABIO/Form 4

Janus Henderson Group PLC

10% OwnerARCA biopharma, Inc. (ABIO) · full profile →Form 4 · filed Jul 26, 2024
Net Buying
Open-Market Buys
$699K
Open-Market Sells
$0
Net Open-Market Flow
$699K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 25, 2024Buy(P)30K$3.05$92K2.1M
Jul 24, 2024Buy(P)7K$3.16$22K2.1M
Jul 24, 2024Buy(P)18K$3.18$57K2.1M
Jul 24, 2024Buy(P)165K$3.20$528K2.1M

Transaction Codes

P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-24-023533) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML